Suppr超能文献

代谢不健康的正常体重个体和代谢健康的肥胖个体患糖尿病和心血管疾病的风险。

Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals.

作者信息

Aung KoKo, Lorenzo Carlos, Hinojosa Marco A, Haffner Steven M

机构信息

Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229.

出版信息

J Clin Endocrinol Metab. 2014 Feb;99(2):462-8. doi: 10.1210/jc.2013-2832. Epub 2013 Nov 20.

Abstract

CONTEXT

The risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (DM) associated with obesity appears to be influenced by the coexistence of other metabolic abnormalities.

OBJECTIVE

We examined the risk of developing CVD and DM in metabolically healthy obese (MHO) and metabolically unhealthy normal weight (MUH-NW) individuals.

DESIGN AND SETTING

We analyzed prospective data of the San Antonio Heart Study, a population-based study among Mexican Americans and non-Hispanic whites (median follow-up, 7.4 y).

PARTICIPANTS

Incident DM and CVD were assessed in 2814 and 3700 participants aged 25 to 64 years, respectively.

MAIN MEASURES

MHO was defined as obesity (body mass index ≥ 30 kg/m(2)) with no more than one metabolic abnormality, and MUH-NW was defined as body mass index <25 kg/m(2) with two or more abnormalities.

RESULTS

In logistic regression models, BMI was associated with incident DM after controlling for demographics, family history of DM, and fasting glucose (odds ratio × 1 SD, 1.7 [95% CI, 1.5-2.0]). Both MUH-NW and MHO individuals had an increased DM risk (2.5 [1.1-5.6] and 3.9 [2.0-7.4], respectively). Similarly, BMI was related to incident CVD after adjusting for demographics and Framingham risk score (1.3 [1.1-1.6]). Incident CVD was also increased in MUH-NW and MHO individuals (2.9 [1.3-6.4] and 3.9 [1.9-7.8], respectively). Results were consistent across gender and ethnic categories.

CONCLUSION

The risk of developing DM and CVD is increased in MUH-NW and MHO individuals. Screening for obesity and other metabolic abnormalities should be routinely performed in clinical practice to institute appropriate preventive measures.

摘要

背景

与肥胖相关的心血管疾病(CVD)和2型糖尿病(DM)风险似乎受其他代谢异常共存的影响。

目的

我们研究了代谢健康的肥胖(MHO)和代谢不健康的正常体重(MUH-NW)个体发生CVD和DM的风险。

设计与地点

我们分析了圣安东尼奥心脏研究的前瞻性数据,这是一项针对墨西哥裔美国人及非西班牙裔白人的人群研究(中位随访时间为7.4年)。

参与者

分别对2814名年龄在25至64岁的参与者评估了新发DM情况,对3700名参与者评估了新发CVD情况。

主要测量指标

MHO定义为肥胖(体重指数≥30kg/m²)且代谢异常不超过一项,MUH-NW定义为体重指数<25kg/m²且存在两项或更多异常。

结果

在逻辑回归模型中,在控制了人口统计学因素、DM家族史和空腹血糖后,BMI与新发DM相关(优势比×1个标准差为1.7 [95%可信区间,1.5 - 2.0])。MUH-NW和MHO个体发生DM的风险均增加(分别为2.5 [1.1 - 5.6]和3.9 [2.0 - 7.4])。同样,在调整了人口统计学因素和弗雷明汉风险评分后,BMI与新发CVD相关(1.3 [1.1 - 1.6])。MUH-NW和MHO个体发生新发CVD的情况也增加(分别为2.9 [1.3 - 6.4]和3.9 [1.9 - 7.8])。结果在性别和种族类别中均一致。

结论

MUH-NW和MHO个体发生DM和CVD的风险增加。临床实践中应常规筛查肥胖及其他代谢异常,以采取适当的预防措施。

相似文献

2
Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study.
PLoS Med. 2020 Oct 30;17(10):e1003351. doi: 10.1371/journal.pmed.1003351. eCollection 2020 Oct.
6
Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study.
Eur Heart J. 2015 Mar 1;36(9):551-9. doi: 10.1093/eurheartj/ehu123. Epub 2014 Mar 26.
7
Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity.
Medicine (Baltimore). 2020 Sep 18;99(38):e22036. doi: 10.1097/MD.0000000000022036.
8
Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study.
Diabetes Care. 2013 Aug;36(8):2388-94. doi: 10.2337/dc12-1971. Epub 2013 Mar 14.

引用本文的文献

1
Differences in fat distribution between metabolically unhealthy people with normal weight versus obesity, NHANES 2011-2018.
BMJ Open Diabetes Res Care. 2025 May 28;13(3):e005118. doi: 10.1136/bmjdrc-2025-005118.
2
Body Mass Index and Cardiovascular Risk Markers: A Large Population Analysis.
Nutrients. 2025 Feb 20;17(5):740. doi: 10.3390/nu17050740.
5
Ultra-Processed Food Intake and Increased Risk of Obesity: A Narrative Review.
Foods. 2024 Aug 21;13(16):2627. doi: 10.3390/foods13162627.
6
Metabolically healthy obesity and risks of cardiovascular disease and all-cause mortality, a matched cohort study: the Shizuoka study.
Int J Obes (Lond). 2024 Aug;48(8):1164-1169. doi: 10.1038/s41366-024-01541-3. Epub 2024 May 18.
7
Metabolically Unhealthy Normal Weight: Prevalence and Associated Factors in an Adult Population from Northwest Colombia.
Diabetes Metab Syndr Obes. 2024 Mar 18;17:1337-1357. doi: 10.2147/DMSO.S449213. eCollection 2024.
8
Fat as a Friend or Foe of the Bone.
Curr Osteoporos Rep. 2024 Apr;22(2):245-256. doi: 10.1007/s11914-024-00864-4. Epub 2024 Feb 28.
10
Effect of Plasma Fibrinogen Levels on the Risk of Stroke in Patients with Type 2 Diabetes: A Systematic Review.
TH Open. 2024 Jan 30;8(1):e72-e80. doi: 10.1055/s-0043-1777344. eCollection 2024 Jan.

本文引用的文献

1
Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?
Diabetes Care. 2013 Aug;36(8):2294-300. doi: 10.2337/dc12-1654. Epub 2013 May 1.
2
Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study.
J Clin Endocrinol Metab. 2013 Jun;98(6):2318-25. doi: 10.1210/jc.2012-4253. Epub 2013 Apr 4.
3
Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study.
Diabetes Care. 2013 Aug;36(8):2388-94. doi: 10.2337/dc12-1971. Epub 2013 Mar 14.
5
Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans.
Clin Endocrinol (Oxf). 2013 Sep;79(3):364-70. doi: 10.1111/cen.12154. Epub 2013 May 11.
6
The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness.
Eur Heart J. 2013 Feb;34(5):389-97. doi: 10.1093/eurheartj/ehs174. Epub 2012 Sep 4.
7
Are there still healthy obese patients?
Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):341-6. doi: 10.1097/MED.0b013e328357f0a3.
8
Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality.
J Clin Endocrinol Metab. 2012 Jul;97(7):2482-8. doi: 10.1210/jc.2011-3475. Epub 2012 Apr 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验